May 16-19, 2004, Crystal Gateway Marriott, Arlington, VA
CONTRIBUTED
ISSUES PANEL PROPOSAL INSTRUCTIONS
Contributed Issues Panels are designed to stimulate discussion and debate on
new or controversial issues in health economic/pharmacoeconomic and outcomes
research or use of outcomes research in health care decision-making. An
Issue Panel is composed of a moderator and 1 or 2 speakers/discussants.
The following are some suggested topics: health care coverage reform,
health care reimbursement reform, use of health economic/pharmacoeconomic
information by decision-makers, valuation (preference-based) study issues,
issues in implementation of treatment guidelines, international comparison
of health care reforms, drug reimbursement and new drug development, new
drug/health care regulations, patient reported outcomes methodological
issues.
Proposals must be emailed in a Word document to
issuepanel@ispor.org. Late
submissions will NOT be considered.
The Issues Panel submission should be no longer than 300 words (including
moderator and panelist information).
The deadline for submitting proposals is January 12,
2004, 11:59 PM US Pacific Daylight Savings Time
THE FOLLOWING INFORMATION MUST BE INCLUDED
IN YOUR ISSUES PANEL SUBMISSION:
Title: Full title of your Issue Panel
Moderator and/or Contact Person: Name, degrees, position, and full
contact information for the Moderator of the Issue Panel
Panelists: Names, degrees, positions, and full contact information
for the Issue Panelists. A maximum of two panelists is suggested. Each
panelist should represent a different point of view.
Purpose: The purpose of the Issues Panles should be described.
Overview: A complete description of the issue(s) should be
included.
PRESENTATION OF CONTRIBUTED ISSUE PANELS
• All Issues Panels will be 60 minutes.
• An LCD projector screen and microphones will be provided. However, YOU
MUST BRING YOUR OWN LAPTOP COMPUTER.
REVIEW PROCESS AND NOTIFICATION OF MODERATOR:
All Issue Panel proposals are reviewed by the Issue Panel Chair(s).
Proposals will be evaluated based on relevance and completeness of
information presented based on the criteria given above. The moderator
and/or contact person listed in the proposal will be notified no later than
Monday, March 1, 2004 regarding acceptance and placement in the Meeting
program. All costs associated with the presentation of Contributed Issue
Panels are the sole responsibility of the moderator and panelists.
CONTRIBUTED ISSUE
PANEL PROPOSAL EXAMPLE
TITLE
MODERATOR
WHAT INCENTIVE DO PHARMACEUTICAL FIRMS
HAVE FOR PHARMACOGENOMICS?
Moderator: Adrian Towse PhD, Director, Office of Health Economics,
London, UK
PANELISTS
INSTITUTION(S),
CITY, STATE,
COUNTRY
Panelists:
David Veenstra, PharmD PhD, Assistant Professor,
Pharmaceutical Outcomes Research and Policy Program (PORPP) and
Institute for Public Health Genetics, University of Washington, Seattle,
WA, USA; James Jarrett, MA, Research Associate, Cambridge Genetics
Knowledge Park Cambridge UK, University of East Anlgia, Norwich, UK
PROVIDE
A CLEAR
DESCRIPTION
OF YOUR
ISSUE PANEL
Purpose: The purpose of this Issues Panel is to present drug marketing
and development issues
concerning individualized drug therapy based on pharmacogenomics.
Overview: There is some evidence that using pharmacogenomics to
individualize drug therapy may in some cases offer improved drug
effectiveness and reduce side effects. However, because of the need to
target pharmacogenomics, producers may see a limited and therefore
unacceptable market and will not invest. On the other hand,
pharmacogenomics could have the potential to create monopolies for
producers and therefore the possibility of lucrative investment
opportunities.
